Private companies that grant stock options to employees face a choice: register the securities with the U.S. Securities and Exchange Commission (SEC) or find an exemption. Rule 701 is that exemption. Two numbers get misquoted constantly. The sales limit is the greatest of three figures, not a flat cap, and $10 million is a disclosure trigger, not a ceiling. The SEC’s Rule 701 small-business page confirms both.
What Is Rule 701?
Rule 701 (17 CFR § 230.701) exempts offers and sales of securities made under a written compensatory benefit plan or written compensation contract from registration under the Securities Act of 1933, for private non-reporting companies. The full text of 17 CFR § 230.701 sets the conditions.
Three precision points matter. Rule 701 is an exemption adopted under Section 3(b) authority of the Securities Act, which lets the SEC exempt small or limited offerings; practitioners call it a safe harbor because meeting its conditions gives certainty. It is a transactional exemption, so securities issued are restricted securities. It covers compensatory transactions only and cannot be used to raise capital.
A written plan or contract is a mandatory foundational condition. Rule 701(c) exempts offers and sales only when made under a written compensatory benefit plan or written compensation contract. No written instrument means no exemption.
Who Is Eligible Under Rule 701?
Issuers must be non-reporting private companies that are not investment companies. Recipients include employees, directors, officers, general partners, and trustees. Rule 701(c) also covers consultants and advisors, former service providers who were serving when the securities were offered, and family members who receive securities through a gift or domestic relations order.
Once a company becomes a reporting company after an initial public offering (IPO), it typically moves to Form S-8 for registered plan offerings.
Do consultants and advisors qualify under Rule 701?
Consultants and advisors qualify only if they are natural persons who provide bona fide services to the issuer, and those services are not connected to a capital-raising transaction and do not directly or indirectly promote or maintain a market for the issuer’s securities, per 17 CFR 230.701(c)(1). Entities are excluded, with a narrow exception for entities substantially owned by the service provider.
The common startup failure mode is advisor equity granted for fundraising introductions. That service is connected to a capital-raising transaction, so it does not qualify.
What Securities Can You Issue Under Rule 701?
Rule 701 covers stock options, restricted stock, restricted stock awards (RSAs), restricted stock units (RSUs), and other securities. Each must be issued under a written compensatory benefit plan or written compensation contract, per 17 CFR 230.701(c). The written-instrument requirement applies to every instrument type.
Each instrument is valued differently for the limits. Options count at their exercise price, RSUs and RSAs count at their sale price or value. The calculation section below covers the mechanics.
What Are the Rule 701 Sales Limits?
In any consecutive 12-month period, aggregate sales may not exceed the greatest of $1,000,000, 15% of the issuer’s total assets, or 15% of the outstanding amount of the class being sold, per 17 CFR 230.701(d)(2). Both 15% figures are measured at the most recent balance sheet date. The $1 million figure is a floor, not a cap.
The original framing of $1 million as the cap was wrong. The SEC’s small-business page states a company can sell at least $1 million regardless of size, and more if it meets the asset or share-count formulas.
| Prong | What it measures | Measurement date | Source |
|---|---|---|---|
| $1,000,000 | Fixed dollar floor for any issuer | Not applicable | 17 CFR 230.701(d)(2) |
| 15% of total assets | Issuer’s total assets | Most recent balance sheet date | 17 CFR 230.701(d)(2) |
| 15% of outstanding class | Outstanding amount of the class sold | Most recent balance sheet date | 17 CFR 230.701(d)(2) |
How Do You Calculate Aggregate Sales Under Rule 701?
Options count at their exercise price, measured at grant regardless of whether they are exercised, per 17 CFR 230.701(d). Securities priced by a formula use fair value at grant or sale. RSUs and RSAs count at their sale price or value.
Consider a worked example. A startup has $2 million in total assets. Its cap is the greatest of $1,000,000, $300,000 (15% of assets), or 15% of the outstanding class. The $1 million floor governs, because it exceeds the asset-based figure.
How Does the 12-Month Period Work: Rolling or Fixed?
Rule 701 applies its limits to any consecutive 12-month period, per 17 CFR 230.701(d). This is inherently a rolling test. Issuers must confirm that no such window exceeds the greatest-of limit or the disclosure threshold.
The rule is not an elective accounting method. Companies may track internally on a fixed calendar or plan year for convenience, but the compliance test still runs against any consecutive 12-month window. The rolling analysis is the correct approach.
What Are the Rule 701 Disclosure Requirements?
Every recipient must receive a copy of the plan or contract, per 17 CFR 230.701(e). If aggregate sales in any consecutive 12-month period exceed $10 million, the issuer must also deliver risk disclosures and financial statements a reasonable period before the sale. The $10 million figure governs what you disclose, not how much you can sell.
The SEC’s July 2018 adopting release, No. 33-10520, raised this threshold from $5 million to $10 million. It implemented Section 507 of the Economic Growth, Regulatory Relief, and Consumer Protection Act (Public Law 115-174).
| Sales level (12 months) | Required disclosure | Timing | Source |
|---|---|---|---|
| Any Rule 701 sale | Copy of the written plan or contract | Baseline | 17 CFR 230.701(e) |
| Over $10 million | Plan copy, risk factors, financial statements dated within 180 days | Reasonable period before sale | 17 CFR 230.701(e) |
| Threshold change | Raised from $5M to $10M | Effective July 23, 2018 | SEC Release No. 33-10520 |
Rule 701 vs Form S-8: Which One Applies?
Rule 701 is for non-reporting private companies. Form S-8 is the registration statement reporting companies use for employee benefit plan offerings after an IPO. Companies transition from Rule 701 to Form S-8 once they become subject to reporting requirements.
| Dimension | Rule 701 | Form S-8 | Source |
|---|---|---|---|
| Issuer type | Private, non-reporting | Public, reporting | SEC Rule 701 page |
| Registration | Exemption, no SEC filing | Registration statement | 17 CFR 230.701 |
| Disclosure | Plan copy; more over $10M | S-8 prospectus | 17 CFR 230.701(e) |
| Resale status | Restricted securities | Generally freely tradable | 17 CFR 230.701(g) |
What Happens If You Violate Rule 701?
Exceeding the limits or failing the disclosure conditions makes the exemption unavailable for the non-compliant sales. That creates a Section 5 violation under the Securities Act of 1933. Recipients gain rescission rights, and the issuer faces civil liability and SEC enforcement.
Non-compliance also surfaces in due diligence during financings, mergers, and IPOs, where it can force a costly rescission offer or cleanup.
Does Rule 701 Cover State Securities Laws?
No. Rule 701 is a federal exemption only and does not preempt state blue sky laws. Issuers still need a state-level exemption in each relevant state where securities are offered or sold.
This is a frequent oversight. Federal compliance under Rule 701 does not clear the state layer, so equity compensation programs need a parallel state analysis.
How Do Startups Comply With Rule 701? A Checklist
Compliance comes down to seven steps you can track. Adopt a written compensatory plan or contract before granting anything. Then work through the list below to stay inside the exemption.
- Adopt a written compensatory benefit plan or compensation contract.
- Confirm each recipient is eligible under Rule 701(c).
- Track aggregate sales against the greatest-of test on a consecutive 12-month basis.
- Monitor the $10 million disclosure trigger and keep financials ready.
- Deliver required disclosures before sale once the threshold is crossed.
- Keep grant records: cap table, grant dates, exercise prices, board approvals.
- Plan the Form S-8 transition before an IPO.
How Commenda Helps With Equity Compensation Compliance
The Rule 701 sales-limit formula and the $10 million disclosure trigger are tracking problems. Miss either one and you lose the exemption for the non-compliant sales. Both require watching every grant against a rolling 12-month window across each entity you operate.
Commenda’s entity management platform keeps your corporate records, filings, and compliance obligations tracked in one place as you scale across jurisdictions. Pair it with Commenda’s compliance calendar to keep every filing deadline visible by entity, so a disclosure trigger never slips past.
Book a demo to see every compliance deadline for your entities in one calendar.
